GSK plc (GLAXF)
| Market Cap | 66.03B |
| Revenue (ttm) | 41.97B |
| Net Income (ttm) | 3.37B |
| Shares Out | n/a |
| EPS (ttm) | 0.81 |
| PE Ratio | 19.62 |
| Forward PE | n/a |
| Dividend | 0.57 (3.40%) |
| Ex-Dividend Date | Nov 14, 2024 |
| Volume | 28,200 |
| Average Volume | 6,566 |
| Open | 16.86 |
| Previous Close | 16.51 |
| Day's Range | 16.86 - 16.86 |
| 52-Week Range | 15.77 - 23.00 |
| Beta | 0.33 |
| RSI | 47.40 |
| Earnings Date | Jan 31, 2025 |
About GSK plc
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled... [Read more]
Financial Performance
In 2023, GSK plc's revenue was 30.33 billion, an increase of 3.42% compared to the previous year's 29.32 billion. Earnings were 4.93 billion, a decrease of -67.05%.
Financial numbers in GBP Financial StatementsNews
Why CureVac (CVAC) Shares Are Volatile
CureVac BV (NASDAQ: CVAC) shares have been volatile over the past week, gaining some 25% to $4.23, amid increased trading volume following the U.S.’s first human death from H5N1 bird flu . What To Kn...
Why Novavax Stock Is Volatile This Week
Novavax Inc (NASDAQ: NVAX) shares dipped 11.2% to $9.60 during Wednesday’s session, pulling back following recent strength. Shares of vaccine makers are volatile this week after the first bird flu de...
GSK Nears $1 Billion Deal for Biotech Company IDRx
GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio.
Why CureVac (CVAC) Stock Is Moving
Shares of CureVac BV (NASDAQ: CVAC) fell by 12.3% to $4.10 Wednesday afternoon. The pullback could be due to profit-taking after Tuesday's strong gains , which were fueled by heightened concerns over...
GSK is said to be nearing $1B deal to acquire U.S. biotech IDRx
GSK nears $1bn deal for biotech developing drug for rare tumour
IDRx tests treatment for digestive system cancer that affects 4,000 to 6,000 people a year in US
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
The U.S. Food and Drug Administration (FDA) has mandated updates to the safety labeling for Pfizer Inc’s (NYSE: PFE) Abrysvo and GSK plc’s (NYSE: GSK) Arexvy respiratory syncytial virus (RSV) vaccin...
Wave Life Sciences Is A Buy On Pipeline Prospects
Wave Life Sciences shows promising data in genetic mutation treatments, with GSK collaborations and strong financial footing. See why WVE stock is a Buy.
GSK and Pfizer's RSV vaccines to carry warnings of neurological disorder risk
The regulator conducted a postmarketing trial which suggested increased risk of Guillain-Barr syndrome (GBS) 42 days following vaccination
GSK and Pfizer's RSV vaccines to carry warnings of neurological disorder risk
GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on Tu...
GSK, Pfizer RSV shots to get warning of rare neurological disorder
GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk
GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they can cause a rare neurological side effect, the US Food and Drug Administration said.
GSK gets approval in China for Nucala for rhinosinusitis
GSK COVID antiviral authorization for sotrovimab revoked by FDA
GSK reports mixed results from Phase 3 ovarian cancer study
GSK's cancer drugs meet progression-free survival goal in late-stage trial
GSK said on Friday the addition of its cancer drug Jemperli to both standard of care chemotherapy and Zejula maintenance improved survival in patients with advanced ovarian cancer without the disease ...
Pharmaceutical leaders convene in Paris to unveil vaccine strategies
Pfizer, Sanofi, Moderna, GSK and Novavax confirmed their attendance to Euractiv. The post Pharmaceutical leaders convene in Paris to unveil vaccine strategies appeared first on Euractiv .
European Activist Investor Bluebell Capital to Shut Hedge Fund
Bluebell Capital Partners, the European activist investment firm, is shutting down its hedge fund after targeting high-profile companies from pharmaceutical giant GSK Plc to luxury conglomerate Richem...
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
Shobie Ramakrishnan has helped transform GSK into a data-led company, helping speed up drug discovery.
Pharma stocks: Divi’s Lab (+0.82%), IPCA (+0.83%) rise; Biocon (-1.86%), Glaxo (-1.44%) decline
The pharma sector showed a mixed trend during intraday trading as of 11:25 AM, with select stocks gaining while others faced selling pressure. Key Performances: Gaining Stocks: IPCA Laboratories: Up 0...
GSK Is Doing The Right Things But Can't Catch A Break - Rating Downgrade
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
FOR IMMEDIATE RELEASE Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
Boost for GSK as new bone marrow cancer drug drastically cuts risk of death in patients
The results will be welcomed by boss Emma Walmsley (pictured), who has been trying to improve the pipeline of new drugs and vaccines.
GSK's belantamab mafodotin reduced death risk by 42% in study
GSK's drug combo shown to cut risk of death by 42% in type of blood cancer
British drugmaker GSK said on Monday its experimental cancer drug Blenrep in combination with other treatments reduced the risk of death by 42% in multiple myeloma, a common type of blood cancer, at o...